Despite the hundreds of kinase inhibitors currently in discovery and pre-clinical phases, the number of kinase inhibitors which have been approved and are on the market remains low by comparison. This discrepancy reflects the challenges which accompany the development of ATP-competitive kinase inhibitors, including low specificity and off-target binding. There is also the problem of gatekeeper-associated drug resistance. To remain competitive in the kinase field, it will require you to stay abreast with recent development trends and technological advancements aimed at circumventing these issues. We will also provide you with a broad overview of the role kinases play in various types of cancer as well as introduce you to several novel kinases and inhibitor candidates.
GTCbio is proud to present our 8th Protein Kinases in Drug Discovery Conference! This meeting will be held July 8-9, 2013 at the Westin Copley Place Boston Hotel in historical Boston, Massachusetts, one of the most concentrated academic and industrial areas in the United States. We will bring together industry leaders from major pharmaceutical companies, biotech companies as well as top researchers from academia and government to provide you with a better understanding of the complex activities of kinases and some solutions to the challenges associated with kinase drug development. The meeting will offer you an intimate forum to engage in discourse with other distinguished researchers involved in the most cutting-edge kinase work!